Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Vitamin D Deficiency in Adolescent Girls
Vitamin D Deficiency in Adolescent Girls
Status: Enrolling
Updated:  4/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Vitamin D Deficiency in Adolescent Girls
Vitamin D Deficiency in Adolescent Girls
Status: Enrolling
Updated: 4/18/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Pediatric Appendicitis Pathway Study
Pediatric Appendicitis Pathway Study
Status: Enrolling
Updated:  5/1/2012
Oregon Health and Science Univerisity
mi
from
Portland, OR
Pediatric Appendicitis Pathway Study
Pediatric Appendicitis Pathway Study
Status: Enrolling
Updated: 5/1/2012
Oregon Health and Science Univerisity
mi
from
Portland, OR
Click here to add this to my saved trials
rTMS Bimodal Treatment For Tinnitus: A Pilot Study
rTMS Bimodal Treatment For Patients With Subjective Idiopathic Tinnitus: A Pilot Study
Status: Enrolling
Updated:  5/1/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
rTMS Bimodal Treatment For Tinnitus: A Pilot Study
rTMS Bimodal Treatment For Patients With Subjective Idiopathic Tinnitus: A Pilot Study
Status: Enrolling
Updated: 5/1/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Topical Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
Status: Enrolling
Updated:  5/3/2012
Alcon Call Center
mi
from
Fort Worth, TX
Topical Treatment of Acute Otitis Media With Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora
Topical Treatment of Acute Otitis Media Through Tympanostomy Tubes (AOMT) and Its Effect on Microbial Flora Distal to the Site of Infection
Status: Enrolling
Updated: 5/3/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Nebivolol in the Supine Hypertension of Autonomic Failure
Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity
Status: Enrolling
Updated:  5/10/2012
Vanderbilt University
mi
from
Nashville, TN
Nebivolol in the Supine Hypertension of Autonomic Failure
Effect of Nebivolol on Blood Pressure in a Model of Hypertension Sensitive to Potentiation of Nitric Oxide Bioactivity
Status: Enrolling
Updated: 5/10/2012
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
Status: Enrolling
Updated:  5/15/2012
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
Status: Enrolling
Updated: 5/15/2012
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Vitamin D3 Supplementation Pilot Study
Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents
Status: Enrolling
Updated:  5/15/2012
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Vitamin D3 Supplementation Pilot Study
Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents
Status: Enrolling
Updated: 5/15/2012
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
NSAID RCT for Prevention of Altitude Sickness
Prospective, Double-blind, Randomized, Placebo-controlled Trial of Ibuprofen Versus Placebo for Prevention of Neurologic Forms of Altitude Sickness
Status: Enrolling
Updated:  5/23/2012
Marine Mountain Warfare Training Center
mi
from
Bridgeport, CA
NSAID RCT for Prevention of Altitude Sickness
Prospective, Double-blind, Randomized, Placebo-controlled Trial of Ibuprofen Versus Placebo for Prevention of Neurologic Forms of Altitude Sickness
Status: Enrolling
Updated: 5/23/2012
Marine Mountain Warfare Training Center
mi
from
Bridgeport, CA
Click here to add this to my saved trials
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Observational Study to Evaluate Changes in Iron, Vit-D, and CRP During a Twelve to Twenty-Four Week Supervised Triathlon Training Program
Status: Enrolling
Updated:  5/31/2012
Avera Sports Institute
mi
from
Sioux Falls, SD
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Observational Study to Evaluate Changes in Iron, Vit-D, and CRP During a Twelve to Twenty-Four Week Supervised Triathlon Training Program
Status: Enrolling
Updated: 5/31/2012
Avera Sports Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Earset Healthy Volunteer Study
Performance of the Acclarent Iontophoresis System With Earset (IPSES) in Healthy Volunteers
Status: Enrolling
Updated:  5/31/2012
CEI Medical Group
mi
from
East Palo Alto, CA
Earset Healthy Volunteer Study
Performance of the Acclarent Iontophoresis System With Earset (IPSES) in Healthy Volunteers
Status: Enrolling
Updated: 5/31/2012
CEI Medical Group
mi
from
East Palo Alto, CA
Click here to add this to my saved trials
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Arizona Ear Center
mi
from
Phoenix, AZ
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Arizona Ear Center
mi
from
Phoenix, AZ
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
California Hearing and Balance Center
mi
from
LaJolla, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
California Hearing and Balance Center
mi
from
LaJolla, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Shohet Ear Associates Medical Group
mi
from
Newport Beach, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Shohet Ear Associates Medical Group
mi
from
Newport Beach, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Camino Ear, Nose and Throat Clinic
mi
from
San Jose, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Camino Ear, Nose and Throat Clinic
mi
from
San Jose, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Hearing Resource Center
mi
from
San Mateo, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Hearing Resource Center
mi
from
San Mateo, CA
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
The George Washington University- Department of Otolaryngology
mi
from
Washington,
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
The George Washington University- Department of Otolaryngology
mi
from
Washington,
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
University of Miami Miller School of Medicine
mi
from
Miami, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
University of Miami Miller School of Medicine
mi
from
Miami, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Physicians Choice Hearing and Dizziness Center
mi
from
Tampa, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Physicians Choice Hearing and Dizziness Center
mi
from
Tampa, FL
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Henry Ford Health System- Department of Otolayrngology and Audiology
mi
from
Detroit, MI
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Henry Ford Health System- Department of Otolayrngology and Audiology
mi
from
Detroit, MI
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
New York Otology
mi
from
New York, NY
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
New York Otology
mi
from
New York, NY
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Carolina Ear and Hearing Clinic, PC
mi
from
Raleigh, NC
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Carolina Ear and Hearing Clinic, PC
mi
from
Raleigh, NC
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
Ear Medical Group
mi
from
San Antonio, TX
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
Ear Medical Group
mi
from
San Antonio, TX
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated:  6/5/2012
University Health Science Center (University of Utah Hospital)
mi
from
Salt Lake City, UT
SoundBite Hearing System Long Term Multi Site Patient Use Study
SoundBite Hearing System Long Term Multi Site Patient Use Study
Status: Archived
Updated: 6/5/2012
University Health Science Center (University of Utah Hospital)
mi
from
Salt Lake City, UT
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Southwest Autism Research and Resource Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Miller Children's Hospital Research Administration
mi
from
Long Beach, CA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Miller Children's Hospital Research Administration
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
University of California, Davis, M.I.N.D. Institute
mi
from
Sacramento, CA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of California, Davis, M.I.N.D. Institute
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
University of Colorado Denver, Children's Hospital
mi
from
Aurora, CO
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Colorado Denver, Children's Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
University of Miami, Mailman Center for Child Development
mi
from
Miami, FL
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Miami, Mailman Center for Child Development
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Lake Mary Pediatrics
mi
from
Orange City, FL
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Lake Mary Pediatrics
mi
from
Orange City, FL
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Emory University School of Medicine
mi
from
Atlanta, GA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Rush University Medical Center
mi
from
Chicago, IL
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Riley Hospital for Children
mi
from
Indianapolis, IN
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Kennedy Krieger Institute
mi
from
Baltimore, MD
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
University of Massachusetts
mi
from
Worcester, MA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
University of Missouri, Thompson Research Center for Autism & Neurodevelpmental Disorders
mi
from
Columbia, MO
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Missouri, Thompson Research Center for Autism & Neurodevelpmental Disorders
mi
from
Columbia, MO
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Seaver Autism Center, Mount Sinai Medical Center
mi
from
New York, NY
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Seaver Autism Center, Mount Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
New York State Institute for Basic Research in Developmental Disabilities
mi
from
Staten Island, NY
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
New York State Institute for Basic Research in Developmental Disabilities
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Duke University Clinical Research Unit
mi
from
Durham, NC
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Duke University Clinical Research Unit
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Akron Children's Hospital
mi
from
Akron, OH
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Akron Children's Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
University of Oklahoma, Physician's Child Study Center
mi
from
Oklahoma City, OK
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
University of Oklahoma, Physician's Child Study Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Suburban Research Associates/Elwyn Genetics
mi
from
Media, PA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Suburban Research Associates/Elwyn Genetics
mi
from
Media, PA
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Vanderbilt Kennedy Center
mi
from
Nashville, TN
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Vanderbilt Kennedy Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Red Oaks Psychiatry Associates, P.A.
mi
from
Houston, TX
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Red Oaks Psychiatry Associates, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Road Runner Research
mi
from
San Antonio, TX
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated:  6/6/2012
Seattle Children's Hospital
mi
from
Seattle, WA
A Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
Status: Enrolling
Updated: 6/6/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay
Acquisition of Saliva Samples for Validation as a Specimen Type in the Esoterix Genetic Laboratories Fragile X Assay
Status: Enrolling
Updated:  6/7/2012
Integrated Genetics
mi
from
Westborough, MA
Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay
Acquisition of Saliva Samples for Validation as a Specimen Type in the Esoterix Genetic Laboratories Fragile X Assay
Status: Enrolling
Updated: 6/7/2012
Integrated Genetics
mi
from
Westborough, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
A Randomized, Double-blind, Placebo-controlled, Study of Safety and Efficacy of Dutasteride in Combination With Tolterodine ER or Placebo in Men With Lower Urinary Tract Symptoms (LUTS) Including Urgency and Frequency
Status: Enrolling
Updated:  6/8/2012
Deaconess Clinic Gateway Health Center
mi
from
Newburgh, IN
Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
A Randomized, Double-blind, Placebo-controlled, Study of Safety and Efficacy of Dutasteride in Combination With Tolterodine ER or Placebo in Men With Lower Urinary Tract Symptoms (LUTS) Including Urgency and Frequency
Status: Enrolling
Updated: 6/8/2012
Deaconess Clinic Gateway Health Center
mi
from
Newburgh, IN
Click here to add this to my saved trials
Cochlear Implant PDA Based Research Platform
Multi Center Clinical Study to Assess the Safety of the UTD Cochlear Implant PDA (ciPDA) REsearch Platform
Status: Enrolling
Updated:  6/12/2012
University of Texas - Dallas
mi
from
Richardson, TX
Cochlear Implant PDA Based Research Platform
Multi Center Clinical Study to Assess the Safety of the UTD Cochlear Implant PDA (ciPDA) REsearch Platform
Status: Enrolling
Updated: 6/12/2012
University of Texas - Dallas
mi
from
Richardson, TX
Click here to add this to my saved trials
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1
Status: Enrolling
Updated:  6/22/2012
John Jay High School
mi
from
Cross River, NY
How Neurofibromatosis Type 1 (NF1) Affects Schoolwork and Self-Esteem
Cognitive Impairments, Self-Esteem & Academic Performance in Teenagers With Neurofibromatosis Type 1
Status: Enrolling
Updated: 6/22/2012
John Jay High School
mi
from
Cross River, NY
Click here to add this to my saved trials
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Status: Enrolling
Updated:  6/27/2012
Brigham and Women's Hospital Jen Center for Primary Care
mi
from
Boston, MA
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
Status: Enrolling
Updated: 6/27/2012
Brigham and Women's Hospital Jen Center for Primary Care
mi
from
Boston, MA
Click here to add this to my saved trials